Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 16 | 2021 | 193 | 4.580 |
Why?
|
| Saccharomyces cerevisiae Proteins | 11 | 2021 | 112 | 3.730 |
Why?
|
| Myosin Type II | 4 | 2016 | 18 | 1.400 |
Why?
|
| Antifungal Agents | 4 | 2019 | 147 | 1.330 |
Why?
|
| Gene Expression Regulation, Fungal | 5 | 2020 | 72 | 1.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2020 | 184 | 0.970 |
Why?
|
| Membrane Proteins | 4 | 2020 | 486 | 0.890 |
Why?
|
| Cell Wall | 5 | 2020 | 53 | 0.780 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 135 | 0.760 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 45 | 0.760 |
Why?
|
| Protein Interaction Mapping | 2 | 2021 | 57 | 0.750 |
Why?
|
| Myosin Heavy Chains | 2 | 2010 | 19 | 0.700 |
Why?
|
| Saccharomycetales | 1 | 2018 | 7 | 0.670 |
Why?
|
| Azoles | 1 | 2018 | 13 | 0.670 |
Why?
|
| Mycoses | 1 | 2018 | 29 | 0.660 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2018 | 23 | 0.660 |
Why?
|
| Cell Polarity | 1 | 2018 | 53 | 0.650 |
Why?
|
| Stress, Physiological | 1 | 2019 | 137 | 0.640 |
Why?
|
| Triazoles | 1 | 2018 | 85 | 0.630 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 197 | 0.620 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 600 | 0.470 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 550 | 0.430 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 756 | 0.390 |
Why?
|
| Hepatitis C | 3 | 2014 | 120 | 0.380 |
Why?
|
| Mutation | 3 | 2010 | 1023 | 0.360 |
Why?
|
| Myosins | 3 | 2000 | 25 | 0.350 |
Why?
|
| ras Proteins | 2 | 2019 | 49 | 0.340 |
Why?
|
| Cell Physiological Phenomena | 1 | 2008 | 8 | 0.320 |
Why?
|
| RNA, Messenger | 7 | 2010 | 1152 | 0.320 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2007 | 15 | 0.300 |
Why?
|
| Transcription Factors | 1 | 2012 | 653 | 0.300 |
Why?
|
| Gene Deletion | 1 | 2007 | 156 | 0.290 |
Why?
|
| Fungal Proteins | 4 | 2020 | 130 | 0.280 |
Why?
|
| Chitin | 2 | 2000 | 19 | 0.280 |
Why?
|
| Biomedical Research | 1 | 2009 | 371 | 0.260 |
Why?
|
| Drug Resistance, Fungal | 2 | 2018 | 32 | 0.240 |
Why?
|
| Fungi | 2 | 2018 | 86 | 0.240 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 126 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2019 | 1802 | 0.200 |
Why?
|
| Blotting, Western | 5 | 2010 | 834 | 0.200 |
Why?
|
| Metabolomics | 1 | 2021 | 76 | 0.190 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 140 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2012 | 878 | 0.180 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 173 | 0.180 |
Why?
|
| Computational Biology | 1 | 2021 | 275 | 0.170 |
Why?
|
| Ribosomal Proteins | 3 | 2008 | 19 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 122 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 298 | 0.160 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 181 | 0.160 |
Why?
|
| Down-Regulation | 2 | 2012 | 420 | 0.160 |
Why?
|
| Drug Interactions | 1 | 2018 | 137 | 0.160 |
Why?
|
| Aminoglycosides | 2 | 2008 | 6 | 0.160 |
Why?
|
| Chitin Synthase | 2 | 2012 | 4 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 255 | 0.160 |
Why?
|
| RNA, Fungal | 2 | 2008 | 7 | 0.150 |
Why?
|
| Molecular Structure | 1 | 2018 | 467 | 0.150 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2016 | 49 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 984 | 0.130 |
Why?
|
| Interleukins | 1 | 2014 | 28 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 605 | 0.130 |
Why?
|
| Genome, Fungal | 1 | 1994 | 21 | 0.130 |
Why?
|
| Protein Phosphatase 2 | 2 | 2012 | 22 | 0.120 |
Why?
|
| Introns | 1 | 1994 | 67 | 0.120 |
Why?
|
| Proteomics | 1 | 2016 | 302 | 0.120 |
Why?
|
| RNA Splicing | 3 | 1994 | 36 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2019 | 874 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1149 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2019 | 203 | 0.110 |
Why?
|
| Cytokinesis | 1 | 2012 | 11 | 0.110 |
Why?
|
| Fasciola hepatica | 3 | 2001 | 33 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2012 | 91 | 0.110 |
Why?
|
| Protein Kinase C | 1 | 2012 | 110 | 0.100 |
Why?
|
| Cytoplasmic Structures | 1 | 2010 | 1 | 0.100 |
Why?
|
| Polyribosomes | 1 | 2010 | 3 | 0.100 |
Why?
|
| Peptide Initiation Factors | 1 | 2010 | 5 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 638 | 0.100 |
Why?
|
| HIV Infections | 1 | 2004 | 2207 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 123 | 0.090 |
Why?
|
| Humans | 5 | 2020 | 34853 | 0.090 |
Why?
|
| Antigens, Helminth | 2 | 2001 | 33 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 2008 | 6 | 0.080 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 20 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 901 | 0.080 |
Why?
|
| Models, Biological | 1 | 2010 | 642 | 0.080 |
Why?
|
| Base Sequence | 5 | 1994 | 932 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2002 | 1490 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 490 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 968 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 396 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1984 | 26 | 0.060 |
Why?
|
| Antiviral Agents | 2 | 2014 | 148 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 485 | 0.060 |
Why?
|
| Biopsy | 1 | 2004 | 151 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2001 | 121 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 42 | 0.050 |
Why?
|
| Actins | 1 | 1983 | 142 | 0.050 |
Why?
|
| Osmosis | 1 | 2000 | 7 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 1124 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 203 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2001 | 287 | 0.040 |
Why?
|
| Multigene Family | 2 | 2002 | 105 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 160 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2000 | 196 | 0.040 |
Why?
|
| Cell Death | 1 | 2000 | 260 | 0.040 |
Why?
|
| Animals | 5 | 2010 | 14307 | 0.040 |
Why?
|
| Glucose | 1 | 2000 | 217 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 1997 | 37 | 0.040 |
Why?
|
| Common Variable Immunodeficiency | 1 | 1997 | 27 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 1996 | 37 | 0.040 |
Why?
|
| Serine | 1 | 1996 | 72 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 751 | 0.030 |
Why?
|
| Time Factors | 1 | 2000 | 1681 | 0.030 |
Why?
|
| Genes, Helminth | 1 | 1994 | 7 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 1994 | 5 | 0.030 |
Why?
|
| Ribavirin | 1 | 2014 | 17 | 0.030 |
Why?
|
| Interferons | 1 | 2014 | 34 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 1994 | 11 | 0.030 |
Why?
|
| Spliceosomes | 1 | 1994 | 8 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 80 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 155 | 0.030 |
Why?
|
| RNA Precursors | 1 | 1994 | 25 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1994 | 79 | 0.030 |
Why?
|
| Poly A | 1 | 1994 | 33 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 284 | 0.030 |
Why?
|
| DNA Primers | 1 | 1994 | 269 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2001 | 161 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1994 | 288 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1993 | 83 | 0.030 |
Why?
|
| Registries | 1 | 2014 | 330 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 641 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 528 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1003 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2010 | 31 | 0.020 |
Why?
|
| Immune System | 1 | 2010 | 40 | 0.020 |
Why?
|
| Muscle Development | 1 | 2010 | 44 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 164 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2014 | 1352 | 0.020 |
Why?
|
| Prevalence | 1 | 1994 | 1425 | 0.020 |
Why?
|
| Cell Division | 1 | 1990 | 296 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 287 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2010 | 226 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 249 | 0.020 |
Why?
|
| Phenotype | 1 | 1990 | 650 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1985 | 34 | 0.020 |
Why?
|
| Ribonuclease H | 1 | 1984 | 11 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 781 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1984 | 40 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1985 | 142 | 0.020 |
Why?
|
| Endoribonucleases | 1 | 1984 | 23 | 0.020 |
Why?
|
| Plasmids | 1 | 1984 | 233 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 11034 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 6448 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1983 | 38 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1994 | 430 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 2001 | 9 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 2001 | 16 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2001 | 46 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 2001 | 22 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2001 | 21 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2001 | 24 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 278 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 9642 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 472 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 445 | 0.010 |
Why?
|
| Female | 2 | 2014 | 19873 | 0.010 |
Why?
|
| Hepatitis, Chronic | 1 | 1997 | 5 | 0.010 |
Why?
|
| Drug Contamination | 1 | 1997 | 4 | 0.010 |
Why?
|
| Liver Failure | 1 | 1997 | 7 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1997 | 18 | 0.010 |
Why?
|
| Hepacivirus | 1 | 1997 | 59 | 0.010 |
Why?
|
| Cause of Death | 1 | 1997 | 154 | 0.010 |
Why?
|
| Male | 1 | 2014 | 18870 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1997 | 287 | 0.010 |
Why?
|
| Disease Progression | 1 | 1997 | 580 | 0.010 |
Why?
|
| Prognosis | 1 | 1997 | 707 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 66 | 0.010 |
Why?
|
| Schistosoma japonicum | 1 | 1993 | 1 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1993 | 27 | 0.010 |
Why?
|
| Schistosoma mansoni | 1 | 1993 | 20 | 0.010 |
Why?
|
| Epitopes | 1 | 1993 | 145 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 310 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 549 | 0.010 |
Why?
|
Rodríguez-Medina's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_